Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

AVTX Avalo Therapeutics Inc

7,43

-0,37 (-4,74%)

01 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Avalo Therapeutics Charts.

Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Avalo Therapeutics Charts.

News Avalo Therapeutics Inc

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Dienstag 31 Dezember 2024 (1 Tag vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 5 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
Dienstag 12 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Avalo Therapeutics to Present at Upcoming Investor Conferences
Montag 11 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates
Donnerstag 7 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Avalo Therapeutics Inc News-Artikel

iShares Transition Enabl...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen